2017
DOI: 10.1016/j.bmcl.2016.11.079
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of novel BTK inhibitors with carboxylic acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…However, analogues were shown to inhibit adenosine uptake (AdU) causing undesirable CV effects . To avoid these adverse effects optimization of the drug 310 was carried out by substituting the cyclohexane ring for cubane, BCO, and BCP . The cubane 311 and BCP 313 analogues showed reduced human whole blood (hWB) potency, whereas the BCO 312 analogue exhibited excellent potencies at the desired receptors but was poorly selective for AdU.…”
Section: Application Of Rigid‐linear Linkers In Small Molecule Drugsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, analogues were shown to inhibit adenosine uptake (AdU) causing undesirable CV effects . To avoid these adverse effects optimization of the drug 310 was carried out by substituting the cyclohexane ring for cubane, BCO, and BCP . The cubane 311 and BCP 313 analogues showed reduced human whole blood (hWB) potency, whereas the BCO 312 analogue exhibited excellent potencies at the desired receptors but was poorly selective for AdU.…”
Section: Application Of Rigid‐linear Linkers In Small Molecule Drugsmentioning
confidence: 99%
“…[380] To avoid thesea dverse effects optimizationo ft he drug 310 was carriedo ut by substituting the cyclohexane ring for cubane, BCO, and BCP. [381] The cubane 311 and BCP 313 analogues showed reduced human whole blood (hWB) potency,w hereas the BCO 312 analoguee xhibited excellent potencies at the desired receptors but was poorly selective for AdU. The addition of an ethoxy group onto the centralb enzene ring of the compound 312 b resulted in the retention of good potencyw hile reducing adenosine uptake activity.B ut unfortunately,ahigh metabolic clearance was observed for this compound making further optimizationn ecessary before it can be effective.…”
Section: Aliphatic Bioisosteresmentioning
confidence: 99%
“…Various polycyclic linkers were also explored as inhibitors of Bruton's tyrosine kinase, namely, compounds 80. 93 In all cases, IC 50 values between 0.1 and 0.4 nM were found, indicating great tolerance for this alteration. Potencies translated to human peripheral blood mononuclear cell and human whole blood activity studies.…”
Section: Journal Of Medicinal Chemistrymentioning
confidence: 82%
“…Later, to further optimize potency, selectivity parameters, PK parameters, and to reduce the AdU activity, authors reported other reversible BTKIs with good kinase selectivity and acceptable oral bioavailability. Compound 27 ( Figure 9 ) was the most interesting; like the previous compound, compound 26b , it is characterized by a carboxylic function and inhibits BTKs with IC 50 value of 1 nM, with reduced side effects [ 99 ].…”
Section: Recent Advances In Btkismentioning
confidence: 99%